BLMS — Bloomios Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Bloomios, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.49 | -1.17 | -2.01 | -13.8 |
| Depreciation | ||||
| Non-Cash Items | 0 | 0.15 | 1.14 | 4.93 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.433 | 1.61 | 0.396 | 2.08 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Net Change in Other Assets & Liabilities | ||||
| Cash from Operating Activities | -0.057 | 0.821 | -0.099 | -6.33 |
| Capital Expenditures | 0 | -2.3 | -0.798 | -0.024 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | -0.4 | 0 | — |
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0 | -2.7 | -0.798 | -0.024 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.058 | 1.95 | 1.1 | 6.08 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.001 | 0.071 | 0.198 | -0.271 |